GenoSensor System, showing results of hybridization to biochip (left) and display of data using software (right). Gene amplification and rearrangements have long been known to occur in cancer cells, and the connection between these events and disease outcome is of great interest, especially in light of the relationship between HER-2/neu amplification and a poor breast cancer prognosis. It is with this backdrop that Vysis, a genomic disease management company based in Downer's Grove, Ill., has
 GenoSensor System, showing results of hybridization to biochip (left) and display of data using software (right). |
The PathVysion HER-2/neu DNA probe is not the first of its kind to be offered. However, this kit is unique in that it includes the means to normalize the signal ...
In mammals, intracellular clocks begin to tick within days of fertilization.
View this Issue
Discover how new fluidics technologies help scientists make biological breakthroughs through feats of engineering and computational prowess.
Learn how mastering the ins and outs of PCR can accelerate workflows and improve data.
Molecular detection technologies help scientists rapidly and reliably find and address ever-evolving pathogens with optimal accuracy and sensitivity.
Discover the key features to consider when selecting a new refrigerator or freezer
Mounts directly onto most solvent and reagent bottles for faster and more convenient dispensing. Unique design ensures smooth operation and eliminates wearing parts, autoclavable at 121°C. From acids, organic solvents to hydroflouric acids we have a dispenser for you!
Integration of the NVIDIA BioNeMo platform enhances AI capabilities across the drug discovery lifecycle
DeNovix introduces the Helium 1 µL Spectrophotometer, a new affordable nanovolume spectrophotometer in the DS-Series Quantification Range.
Olink® Reveal is an NGS-based proteomics solution offering high-throughput biomarker analysis with minimal hands-on time. Requiring just 4 µL of sample, it enables deep proteome profiling in 1.5 days, leveraging existing NGS infrastructure for efficient and cost-effective protein analysis.
